NCT04977011 is a NA clinical trial of relaxing music in Diabetic Ketoacidosis, sponsored by Min-Sheng General Hospital.

Who is sponsoring NCT04977011?

NCT04977011 is sponsored by Min-Sheng General Hospital.

What drugs are being tested in NCT04977011?

Interventions in NCT04977011: relaxing music.

What condition does NCT04977011 study?

NCT04977011 studies Diabetic Ketoacidosis, Heart Disease, Ischemic, Stroke, GastroIntestinal Bleeding, Acute Kidney Injury, Heart Failure, Trauma, Septic Shock, Respiratory Failure, Pneumonia, Intracerebral Hemorrhage, Head Injury, Liver Diseases.

Is NCT04977011 still recruiting?

NCT04977011 is currently completed. Last updated 26 July 2021.

Last reviewed 2021-07-26 · How we verify

NCT04977011

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effectiveness of Music Intervention on Anxiety and Physiological Responses in Critical Ill Patient

Completed NA Last updated 26 July 2021

What this trial tests

NA trial testing relaxing music in Diabetic Ketoacidosis in 196 participants. Completed in 30 July 2019.

Timeline

2 January 2019

Primary endpoint
30 June 2019

30 July 2019

Quick facts

Lead sponsor	Min-Sheng General Hospital
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	supportive care
Enrollment	196
Start date	2 January 2019
Primary completion	30 June 2019
Estimated completion	30 July 2019
Sites	1 location across Taiwan

Drugs / interventions tested

relaxing music

Conditions studied

Diabetic Ketoacidosis — all drugs for Diabetic Ketoacidosis →
Heart Disease, Ischemic — all drugs for Heart Disease, Ischemic →
Stroke — all drugs for Stroke →
GastroIntestinal Bleeding — all drugs for GastroIntestinal Bleeding →

Sponsor

Min-Sheng General Hospital

Who can join

Adults 20 to 102, any sex, with Diabetic Ketoacidosis or Heart Disease, Ischemic. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Music intervention is a non-pharmacological and effective intervention that can alleviate anxiety and agitation in patients undergoing weaning. The effectiveness of music intervention in reducing anxiety of patients in Intensive Care Unit (ICU) is still unknown. The purpose of this study was to examine the effectiveness of music intervention on anxiety, agitation, sleep quality and physiological parameters on patients in ICU. This study was conducted from January to June 2019. A total of 196 hospitalized ICU patients were divided into two groups. Subjects in experimental group received 30 minutes music intervention for 3 days on bedside whereas subjects in control group received routine care only. The primary outcome was anxiety. Agitation Sedation Scale, sleep quality and physical parameters were selected to collect as secondary outcomes.There was no significant difference between the groups at baseline. The results of this study support that music can reduce anxiety and agitation levels in ICU's patient. Nurses can incorporate this intervention into the daily care in order to reduce the discomfort of patients.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Diabetic Ketoacidosis

Currently open trials in the same condition.

NCT07167693 — Phase 1 Trial of Arginine Hydrochloride for the Management of Diabetic Ketoacidosis in Type 2 Diabetes · Phase 1, PHASE2 · recruiting
NCT07127406 — Postoperative Euglycemic Ketoacidosis Frequency in Sodium-Glucose Cotransporter-2 Inhibitor Users · active not recruiting
NCT06955416 — REAMBERIN® 1.5% in Rehydration Therapy of Diabetic Ketoacidosis · Phase 2, PHASE3 · recruiting
NCT07193069 — Clinical and Biological Signs of Dapagliflozin Overdose in ICU Patients With Metformin Poisoning · recruiting

Other Min-Sheng General Hospital trials

Trials by the same sponsor.

NCT04637360 — Bone Markers and Bone Density Changes in Hyperperparathyroid Dialysis Patients Under Cinacalcet Treatment · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04977011 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Min-Sheng General Hospital
Last refreshed: 26 July 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04977011.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing